Study drug for kidney failure patients on dialysis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 80 years old.
- You have end-stage kidney disease and get hemodialysis about 3 times per week for at least 90 days.
- Your overall health is stable enough for the study doctor to approve you.
- You can stay on your usual kidney treatment medicines and don’t need extra hospital care beyond routine dialysis.
- You agree to sign informed consent.
- You’re not planning major surgery (including kidney transplant) in the next 4 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called KN060, given to people with end-stage kidney disease on dialysis, to see if it is safe and helps with blood clotting. It may be an option if you are on stable dialysis and not at high risk for bleeding.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.
This trial tests a new drug called AZD7760 in two groups: healthy adults (Phase I) and adults with end-stage kidney disease who are on hemodialysis through a central venous catheter (Phase IIa). The goal is to see how safe the drug is and how the body processes it. This could lead to a new treatment option for people on dialysis.
This trial tests three study drugs (called monoclonal antibodies) in people with end-stage kidney disease who are on hemodialysis. The goal is to see if these drugs are safe and how they affect your body while you're on dialysis.
This is a flexible research study for adults with advanced kidney disease. Depending on which part of the study you qualify for, you may test new treatments designed to slow kidney disease, reduce complications, or improve your health while on dialysis or after transplant.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.